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Abstract 
It has been reported that wounds heal faster and better in a moist, enclosed 
environment. Wound dressings are designed to fulfill such demands. In addition, 
wound dressings protect wounds from subsequent physical harm and bacterial 
infection. Among various types of wound dressings, electrospun wound dressings are 
widely marketed due to desired properties. For instance, electrospun polymers are 
highly porous. Water and oxygen that are necessary for cells are permeable through 
the porous structure. Moreover, electrospun polymers have high surface area to 
volume ratio. This property allows polymers to absorb extra exudate from wounds 
efficiently.  In this study, several silver-releasing electrospun polymers were 
evaluated with respect to their inhibiting activities against bacterial biofilms. 
Additionally, cadmium sulfide quantum dots were used as fluorescence probes to 
measure the silver release of several silver-containing polymers. 
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1 LITERATURE REVIEW 
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1.1 Wound dressings 
A wound dressing is a piece of sterile compress used for covering wounds in order to 
reduce wound bioburden. Wound dressings protect wounds from further harm and 
provide wounds an enclosed, moist, clean environment required for the healing of 
wounds1-4. With different designs and material processing, wound dressings have a 
variety of applications for suppressing bleeding, absorbing extra exudate, preventing 
infection and optimizing healing. Historically, various materials were used as wound 
dressings, including cloth, leaves, honey, and cobwebs5-7. Modern wound dressings 
can be classified into three types7,8:  
 
1. The first type of wound dressings is the passive product, such as ordinary tulle 
and gauze, which act as wound covers with no interactions with wounds. 
Dressings can be impregnated with functional drugs for certain demands. 
 
2. The second type is about interactive wound dressings of polymeric materials. 
These types include semi-permeable films, semi-permeable foams, and hydrogels 
which allow water vapor and oxygen transmission. The semi-permeability also 
blocks microorganisms from entering the wound environment.  
 
3. The last type of wound dressings is the bioactive material, such as hydrocolloids, 
alginates, collagens, and chitosan9-12. Bioactive wound dressings contain active 
functional ingredients, like a variety of antibiotics which were applied to against 
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contaminations and infections. The wide options of dressings fulfill different 
demands of wound treatments. 
 
1.2 Application of electrospun polymers in wound dressings 
In this study, several electrospun polymers were synthesized with silver components 
which were designed for the application in wound dressing. Electrospun polymers are 
composed of nanofibers and created using electrostatic force. A jet of polymeric 
solution produced by the high potential difference between a syringe needle and a 
cylindrical collector forms the nonwoven and highly porous structure of electrospun 
polymers. By adjusting the voltage, collector rotation speed, proportion of polymeric 
solution etc., a number of physical properties of electrospun polymers can be 
modified to meet different demands. Compared with conventional wound dressings, 
electrospun polymers have advantages as follows13:   
 
1. Absorbability: The highly porous structures of electrospun polymers offer a 
very high surface area to volume ratio which effectively increases 
absorbability of water. In this case, wound exudates can be removed more 
efficiently than with conventional dressings. 
 
2. Semi-permeability: The porous structures of electrospun polymers allow gas 
transmission which is critical for cell respiration. Additionally, these structures 
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can hold an appropriate amount of water vapor, which serves to keep the 
environment moist. The fine porous structure can also block microorganism 
invasion while still allowing exchange of air and water permeation, thus 
reducing the risk of bacterial infection while still promoting wound healing. 
 
3. Functional ability: Due to the ease of incorporating therapeutic or other 
functional compounds, multifunctional dressings are readily available. 
 
4. Sustained drug release: Previous studies have shown that, due to the unique 
nanofibrous structure of electrospun polymers, polymers incorporated with 1% 
ionic silver can reach sustained release of silver ions for 2 weeks14. This 
release profile may not be unique for silver; it may also be possible to 
incorporate antibiotics and other therapeutic drugs for similar releasing effects. 
This could allow the replacement interval of dressing to be prolonged which is 
desired for medical care. 
 
In this thesis, several polymer mats were tested, such as POSS-PEG (POSS: 
polyhedral oligosilsesquioxane; PEG: poly(ethylene glycol)), PCL-PEG (PCL: 
polycaprolactone), and PCL-POSS were synthesized with silver compounds by Dr. 
Mather’s group; the surfaces were then tested by growing biofilms on them in 
order to evaluate their capacity to inhibit biofilm growth. 
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1.3 Silver as an antimicrobial 
Silver has been used as an antimicrobial throughout history, documented as early as 
69 BC15. Rich people in ancient Roman used silver tableware to hold and serve food. 
Despite the purpose that silver, as a rare metal at that time, was used to highlight their 
social status, the antimicrobial property of silver was also a reason for its application 
in food serving and cooking, though the mechanism was still unknown at that time. 
Another example is that the ancient Macedonian emperor Alexander the Great was 
said to drink only from silver vessels for hygienic purposes16,17. As soon as bacteria 
were identified as a cause of disease, the antibacterial activities of silver were 
recognized and silver was applied to make antibacterial medicine18. In the late 
nineteen century, a German obstetrician named Crédé used silver nitrate solution as 
eye drops for newborns to prevent eye infection18,19. Later Albert Barnes in 
Philadelphia found that silver nitrate solution is caustic to human tissue and made an 
improvement using a more benign and effective silver product20. At the same time, 
silver nitrate solution was also used to treat burn21. Silver has since been used for a 
variety of hygienic applications. One example is Microdyn, a silver containing protein 
colloid used to kill bacteria and viruses on produce21. Silver has also been used as a 
coating in water filters and on the surface of urinary catheters21,22. Additionally, silver 
nitrate and silver sulfadiazine are commonly used as antimicrobial agents in 
antimicrobial creams and wound dressings.     
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1.4 Mechanism of bacterial killing by silver ions 
Silver is widely used for hygienic purposes due to its broad spectrum antimicrobial 
activity. Although applications of silver for hygienic purposes can be traced back in 
history, the mechanism has only been revealed recently. It is reported that silver ions 
can interact with multiple target sites on or within bacterial cells. These targets 
include intercellular proteins and nucleic acids. The binding of silver to these targets 
results in disruption of metabolism, leading to structural changes in cell membranes 
and finally loss of viability23-25. Binding with DNA and RNA by silver ions also 
causes inhibition of cell division and replication26,27. 
 
1.5 Biofilm 
A biofilm is formed by the aggregation of microorganisms attached to a surface and a 
polysaccharide matrix produced by cells. Various types of biofilms are commonly 
seen in our daily lives. For example, although we seldom notice the biofilm formed at 
the surface on our teeth, one main purpose of brushing one’s teeth is to remove these 
biofilms. Understanding and controlling biofilm formation are important in many 
areas, such as in the food industry, medical services, and water supply systems. Not 
all biofilms are hazardous. Many biofilms play an important role in maintaining the 
ecological balance on earth. In the medical fields, however, biofilms are mostly 
detrimental. Once cells aggregate to form biofilms, they are protected by the 
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extracellular matrix (ECM).When compared to planktonic cells, cells in biofilms are 
10-1000 times more resistant to antibiotics and other antimicrobials28-30. Because of 
biofilms, cells can easily survive treatment with antibiotics or antimicrobials, 
infections associated with biofilms are normally persistent and reoccur due to release 
of cells from biofilm surfaces14. For this reason, it is critical to find ways to inhibit 
biofilm formation on medical devices and wound dressing materials. 
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2 METHODS 
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2.1 Biofilm test with POSS-PEG and PCL-POSS 
2.1.1 Introduction 
Previous work by Wu et al described a long-term biofilm test with POSS-PEG 
electrospun polymer with 1% silver nitrate14. In this study, POSS-PEG was 
electrospun to form nanofibrous webs with a diameter of 150±2 nm containing 1% 
silver nitrate. This highly porous material showed excellent antimicrobial effects. 
During a 14-day biofilm test, POSS-PEG with 1% silver nitrate effectively suppressed 
biofilm growth compared to a nonporous cast film (only 1 day resistance). The result 
indicated that the introduction of electrospinning treatment to polymers allows 
polymers be capable of reaching long-term sustained silver release. 
 
In my study, the same polymer loaded with 1% silver sulfadiazine was tested 
following a similar protocol to compare with the antimicrobial activities of 
POSS-PEG with 1% silver nitrate. A new polymer, PCL-POSS was also tested 
following this test. 
 
2.1.2 Sample Preparation 
The general idea to challenge polymer materials with bacteria is to let bacteria grow 
on surfaces of polymers, which should be immobile. However, POSS-PEG samples 
were too soft to pick up once soaked in water, and the light-weight property makes it 
mobile under the influence of random flows of culture medium. Therefore, one carrier 
chip must be applied to provide mechanical support as well as to keep the sample still 
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during experiments (Fig. 2-1). First, POSS-PEG with 1% silver sulfadiazine or 1% 
silver nitrate and POSS-PEG without silver membranes were cut into 1.0cm × 0.4cm 
rectangular samples. After that, UV sterilization was performed on both sides of each 
sample for 15 minutes. After both sides were sterilized, each sample was wrapped on 
the surface of a glass microscopy cover slide using Parafilm. Cover slides and 
Parafilm were also sterilized in ethanol for 20 minutes. Glass slides carried samples 
throughout the test. 
 
Fig. 2-1. The structure of a piece of sample chip. The design is for easy handling and 
imaging. 
 
2.1.3 UV Sterilization 
POSS-PEG samples cannot be sterilized with ethanol due to the polymer’s solubility 
in ethanol. To sterilize POSS-PEG samples with or without silver sulfadiazine, 
sample pieces were exposed to a UV light source. Both sides of samples were 
exposed to UV for 15 minutes. Samples were wrapped on glass slides after UV 
sterilization as mentioned above. To confirm the effectiveness of sterilization, 
sterilized samples of POSS-PEG with or without silver sulfadiazine were incubated in 
fresh LB medium for three days, and the LB medium was then tested using the CFU 
(colony forming units) method to understand if any cell colonies grew. Samples were 
11 
 
divided into groups by sterilization time: 10, 15, 20 minutes. The result showed that 
15 minutes of sterilization is enough to prevent bacterial contamination in the 
subsequent test. The procedure is showed in Fig. 2-2. 
 
Fig. 2-2. The procedure of the UV sterilization. 
 
2.1.4 Biofilm Growth 
To evaluate the antimicrobial activity of POSS-PEG with 1% silver sulfadiazine or 1% 
silver nitrate, biofilm formation on these surface was monitored for two weeks. To 
grow biofilms, sample carrying glass slides were immersed in petri dishes containing 
20mL Luria Broth (LB) medium. E.coli RP437/pRSH103 was used to inoculate LB 
medium to an optical density (OD600) of 0.05. Tetracycline was added to a 
concentration of 30 μg/mL to maintain the plasmid. Samples were incubated at 37°C 
for 2, 4, 6, 8, 10, 12 and 14 days. To allow long-term biofilm growth, the planktonic 
phase was replaced with fresh LB medium and 30 μg/mL tetracycline every day. E. 
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coli RP 437/pRSH 103 cells were also added at OD600=0.05 to challenge the surfaces 
when replacing the medium. Samples were washed with PBS gently before being 
transferred into fresh LB medium to remove as many non-attached cell clusters as 
possible.  
 
Fig. 2-3. The procedures of the long-biofilm test. 
 
2.1.5 Microscopy and Biomass Quantification 
Antimicrobial activity of POSS-PEG with 1% silver sulfadiazine or 1% silver nitrate 
was evaluated by quantifying the biomass from microscopic 3-D images. Before 
taking images, all samples were washed gently with PBS. Microscopic 3-D image 
stacks were taken after 2, 4, 6, 8, 10, 12 and 14 days of biofilm growth. Five spots 
were randomly picked from each sample for imaging. Each stack of 3-D images 
contained 30 slices with an interval of 2 μm in the Z direction. Exposure times of all 
images (from different groups and different days) were set to 160 milliseconds to 
make sure data were obtained with the same setting. After image collection, all 
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images were exported to COMSTAT put in TIF format. The biomass of samples with 
or without silver was calculated. 
 
2.2 Planktonic phase test with POSS-PEG 
In the biofilm test, two factors may influence cell population in the planktonic phase. 
First, when silver ion concentration in the culture medium reaches a certain level, cell 
proliferation may be inhibited, and cell population decreases. Second, biofilm cells 
attached on samples can return to the planktonic phase. For the silver-free group, 
biofilms build up on sample surfaces faster than on silver-containing groups allowing 
more cells to disperse from biofilm into the planktonic phase. As a result, there might 
be more planktonic growth and reseeding of the biofilm on silver-free samples. 
 
To understand the effects of silver ions on planktonic cells, we followed the cell 
population under the influence of silver-containing samples. Planktonic samples were 
collected from the biofilm cultures to count CFU. Solution samples of 1.0mL each 
were collected from both the silver-containing group and the silver-free group. The 
extracted solution was vortexed and washed with PBS twice to remove any remaining 
LB medium. After washing, cell numbers were counted following standard CFU 
protocol. 
 
14 
 
To further understand the result, a silver ion treatment test was performed to find out 
at what silver ion concentration, the cell population starts to be affected. First, for 
each group, 1mL of cell medium of E.coli RP437/pRSH103 was collected from a 
fresh overnight culture and washed with PBS twice to remove extra LB medium and 
antibiotics. Then, groups of cells resuspended in PBS were treated with different 
concentrations of silver nitrate (0, 0.001 ppm, 0.005 ppm, 0.01 ppm and 0.05 ppm) 
with shaking at 200 rpm at 37 degrees for 2 hours. After the treatment, samples were 
washed with PBS 3 times to remove silver ions, and the drop plate method was used 
to count the cell number. 
 
2.3 Determination of silver release from polymers 
2.3.1 Introduction 
To further understand how silver ions are released from electrospun polymers and 
inhibit biofilm growth, silver ion release was measured using cadmium sulfide 
quantum dots (CdS QDs) as a fluorescent probe. This method has several 
advantages31-33: 
1. Compared with conventional organic fluorescent dyes, QDs have remarkable 
advantages on fluorescence quantum yield, high photobleaching threshold, and 
photostability.  
2. CdS QDs can be easily prepared and are remarkably stable for months at room 
temperature. For this reason, the test is convenient and relatively easy to handle. 
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3. This method do not require delicate measurement devices. A fluorescence reader 
or a fluorescence spectrometer is capable of generating the measurement. 
4. QDs system is very sensitive to the existence of silver ion. This method is able to 
detect a silver concentration as low as 2 × 10−6𝑔 ∙ 𝐿−1. 
 
CdS QDs are synthesized nanoparticles that have unique optical and electronic 
properties. Interactions between silver ions and CdS QDs can change their 
photophysical and photochemical properties34,35. According to Chen et al, a low 
concentration of silver ions is able to increase the luminescence efficiency of CdS 
QDs without wavelength shift in the photoluminescence emission and absorption 
spectra. By measuring fluorescence intensity at a given wavelength of CdS QDs with 
a silver ion concentration in the detection range (2.0 × 10−8 to 1.0 × 10−6 mol/L 
reported in the paper), the silver ion concentration can be calculated based on the 
linear function of C/I in respect to C: 
C
𝐼
=
1
𝐼𝑚𝑎𝑥
C +
1
𝐵𝐼𝑚𝑎𝑥
 
where C is the silver ion concentration; I is the fluorescence intensity 
measured;   𝐼𝑚𝑎𝑥 is the maximal fluorescence intensity; and B is the binding constant. 
For this study, silver-containing samples were soaked in deionized water to a sample 
weight to water volume ratio of 1 g/L. Samples were incubated on a shaker at 80 rpm 
and at 37 degree for 14 days. If all silver ions can be released at the end of the test, 
then the final concentration of silver ion in DI water should be 
1.0g ∙ 𝐿−1 × 1% = 1.0 × 10−2g ∙ 𝐿−1 
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Assuming an average of 7% of the total amount of silver ions released every day, then 
the silver ion concentration in DI water after the first 24 hours of the releasing test 
should be 
1.0 × 10−2g ∙ 𝐿−1 × 7% = 7.0 × 10−4g ∙ 𝐿−1 
Therefore, the range of silver ion concentration in this test is from 7.0 × 10−4g ∙ 𝐿−1 
to  1.0 × 10−2g ∙ 𝐿−1 . By proper diluting sample solution prior to Cds QDs 
fluorescence test, silver ion concentration could be adjusted to be in the detection 
range of this method. 
 
2.3.2 Calculations  
According to the literature31, the binding and desorption between silver ion and QD 
particles follow the Langmuir-type binding isotherm, and depend on the fraction of 
occupied binding sites θ: 
{
Rb = kbC(1 − θ)
Rd = kdθ
 
where Rb is the rate of binding; and Rd is the rate of desorption. Rd is a simple 
function of the fraction of occupied binding sites θ; 
When the particle system reaches equilibrium, Rb = Rd 
ksθ = kbC(1 − θ) 
Define constant B = kb kd⁄ , then the equation can be simplified as 
θ =
BC
1 + BC
 
According to this definition, θ equal to the ratio between the fluorescence obtained at 
given silver ion concentration I and maximal concentration Imax , θ =
I
Imax
, then 
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I
Imax
=
BC
1 + BC
 
By taking the form: 
C
I
=
1
Imax
C +
1
BImax
 
C/I is a linear function in respect to C. 
 
2.3.3 CdS QDs preparation 
The synthesis of CdS QDs follows the protocol reported by Chen et al31,34. First, 1.0 
mM L-cysteine hydrochloride hydrate was dissolved in 100mL deionized water, after 
which the solution was purged with nitrogen gas for 60 minutes under magnetic 
stirring. The pH value of the solution was then adjusted to be within 8.5-9.0 using 0.5 
mM Tris buffer. Next, 0.5 mM of cadmium nitrate was dropped into the solution and 
allowed to react for 30 minutes. Finally, 0.5 mM sodium sulfide (previously dissolved 
in 10 mL deionized water) was carefully added into the solution. All steps were 
performed under magnetic stirring. The product solution was sealed and incubated in 
a 47 degree water bath for 2 h, and unreacted sulfide was removed with nitrogen 
flushing. The product solution was stored at room temperature away from light with 
no precipitate apprearing for a month. 
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Fig. 2-4. Left: the system for the synthesis of cadmium sulfide quantum dots. Right: 
product showing a green-yellow color. 
 
2.3.4 Determination of silver release from polymers 
According to the literature31, C/I is a linear function of silver nitrate concentration, C. 
The linear function was plotted by measuring cadmium sulfide quantum dots- silver 
ion complex samples prepared with standard silver nitrate solution at different 
concentration. The measurement was repeated more than three times to generate a 
standard curve. The measuring procedure was prepared as follows: 50 μL of PBS was 
added to a 1.5 mL centrifuge tube, and then 10 μL of 1.0 × 10−2mol ∙ L−1 L-cysteine 
solution was added in PBS. Different standard silver nitrate solutions were prepared 
by adding silver nitrate to DI water. By adding different amounts of standard solutions 
listed below, a series of silver concentrations required for plotting standard curve 
were obtained: 
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Table 2-1. Different concentration of standard silver solution 
Standard silver nitrate 
solutions 
Volume added in 
centrifuge tube 
Final concentration (after 
100 times dilution) 
1 × 10−4𝑔 ∙ 𝐿−1 
20μL 2 × 10−6𝑔 ∙ 𝐿−1 
40μL 4 × 10−6𝑔 ∙ 𝐿−1 
60μL 6 × 10−6𝑔 ∙ 𝐿−1 
80μL 8 × 10−6𝑔 ∙ 𝐿−1 
1 × 10−3𝑔 ∙ 𝐿−1 
10μL 1 × 10−5𝑔 ∙ 𝐿−1 
20μL 2 × 10−5𝑔 ∙ 𝐿−1 
40μL 4 × 10−5𝑔 ∙ 𝐿−1 
60μL 6 × 10−5𝑔 ∙ 𝐿−1 
80μL 8 × 10−5𝑔 ∙ 𝐿−1 
1 × 10−2𝑔 ∙ 𝐿−1 
10μL 1 × 10−4𝑔 ∙ 𝐿−1 
20μL 2 × 10−4𝑔 ∙ 𝐿−1 
30μL 3 × 10−4𝑔 ∙ 𝐿−1 
 
After adding silver, 15 μL of 5 × 10−4mol ∙ L−1cadmium sulfide quantum dots 
solution were added. Finally, the solution was diluted to a volume of 1.0 mL. After 
vortexing the mixed solution for 10 seconds, the solution was incubated at room 
temperate for 45 minutes before measuring the fluorescence using a plate reader 
(FLx800, Bio-Tek Instruments, Inc.). The fluorescence of CdS QDs was also 
characterized using a fluorescence spectrophotometer (Aqualog, Horiba Scientific). 
 
After the standard curve was generated, the silver ion concentration in the samples 
was determined using the standard curve and equations. 
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3 RESULTS 
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3.1 Images and biomass of POSS-PEG 
Microscopic images from the 1st day to the 14th day were taken (Fig. 3-1). Images 
were collected every two days to follow biofilm growth. From the images of three 
group samples (POSS-PEG with 1% silver nitrate, POSS-PEG with 1% silver 
sulfadiazine and POSS-PEG without silver), a clear difference between 
silver-containing groups and a silver-free group were showed. During the first 4 days 
of the test, both silver-containing groups show strong resistance to biofilm growth. As 
a comparison, for the silver-free samples, biofilms showed up from images collected 
at the 2nd day, and gradually covered the whole surface over time. From the 4th day to 
14th day, biofilms appeared on the silver-containing groups, and a large area on the 
surface of both silver-containing groups was covered by growth, however the 
thickness and density of biofilm growth increased much more slowly when compared 
with silver-free samples. On the 14th day, there was a considerable amount of biofilm 
covering the surface of all three groups; however, silver-containing samples showed 
less biofilm than silver-free samples. 
22 
 
   
 
 
Fig. 3-1. Representative microscopic images of POSS-PEG without silver 
(top),POSS-PEG with 1% silver sulfadiazine (middle) and POSS-PEG with 1% silver 
nitrate (bottom) from the 10th to the 12th day. 
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After the 14-day test, the biofilm attached to the surface of each sample was imaged 
with a fluorescence microscope, and biomass was then calculated by exporting images 
to COMSTAT (Fig. 3-2). During 14 days of culturing, both POSS-PEG with 1% 
silver sulfadiazine and 1% silver nitrate showed significant biofilm inhibition 
compared with POSS-PEG without silver. During the first 6 days, no sign of cell 
cluster was found on either silver-containing group, thus quite a small amount of 
biomass (less than 1𝜇𝑚3/𝜇𝑚2) was gained in each day. After the 6th day, biofilm 
started to increase significantly over time. On the 14th day, POSS-PEG with 1% silver 
nitrate showed 86% less biofilm formation compared with POSS-PEG without silver. 
For POSS-PEG with 1% silver sulfadiazine, 68% reduction in biofilm formation was 
observed compared to POSS-PEG without silver. A gradual increase of biofilm on 
silver-containing samples was observed over time. But the process was much slower 
compared with the biofilm growth rate on the surfaces of POSS-PEG without silver. 
POSS-PEG with 1% silver sulfadiazine appears to be slightly less effective to inhibit 
biofilm formation compared with POSS-PEG with 1% silver nitrate, but the 
difference was not statistically significant (P>0.05). 
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Fig. 3-2. Biomass data calculated by COMSTAT. 
 
3.2 Images and biomass of PCL-POSS 
A subsequent biofilm test with PCL-POSS was performed following the same 
protocol of POSS-PEG tests, except that PCL-POSS samples need to be treated with 
sonication bath (1 hour) before addition of culture medium due to its high 
hydrophobicity.  
 
Fig. 3-3 shows the fluorescence microscopic images collected from the two groups on 
different days(PCL-POSS with 1% silver nitrate and 1% BF-8; and PCL-POSS 
without silver nitrate or BF-8). Unfortunately,  no difference in respect to biofilm 
formation was observed during the 14 days. Biofilms grew similarly on silver & BF-8 
containing groups and the silver & BF-8 free group. 
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Fig. 3-3. Representative microscopic images of PCL-POSS without silver or BF-8 
(top) as well as PCL-POSS with 1% silver nitrate and 1% BF-8 (bottom). 
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After the 14-day test, the biofilm attached to the surfaces of each sample were imaged 
with a fluorescence microscope. From the bar graph (Fig. 3-4), the silver and BF-8 
contained samples show no more biofilm inhibition than the control group. The 
overall amount of biofilm (or biomass) formed on both groups was lower than the 
previous test on POSS-PEG samples without silver component, which suggests the 
material, PCL-POSS, itself may also be resistant to biofilm formation for certain 
reasons.  
 
 
Fig. 3-4. Biomass on PCL-POSS without silver or BF-8 and PCL-POSS with 1% 
silver nitrate and 1% BF-8. The biomass was quantified with COMSTAT. 
 
3.3 Planktonic phase test with POSS-PEG 
The result indicates that the cell population in the planktonic phase after the first 24 
hours of incubation had no significant difference between silver-containing groups 
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and a silver-free group, e.g. all had a cell population around 1.0 × 108 𝑐𝑒𝑙𝑙/𝑚𝐿 (Fig. 
3-5). 
 
Fig. 3-5. The bar graph shows CFU data of the planktonic phase extracted from each 
POSS-PEG groups after one day incubation. The graph indicates cells from the 
planktonic phase were not influenced by silver ion released from POSS-PEG samples. 
 
For a cell concentration over 1 × 109𝑐𝑒𝑙𝑙/𝑚𝐿, which is close to the cell concentration 
in the planktonic phase of biofilm test, 0.05 ppm of silver ion has a negligible killing 
effect (Fig. 3-6). By diluting the cell concentration 100 times prior to the silver ion 
treatment, 0.05 ppm of silver ion was able to reduce the cell concentration from 
~107𝑐𝑒𝑙𝑙/𝑚𝐿 to ~106𝑐𝑒𝑙𝑙/𝑚𝐿 (Fig. 3-7). This result indicates that a silver ion 
concentration close to 0.05 ppm has little influence on a cell culture 
containing ~109𝑐𝑒𝑙𝑙/𝑚𝐿. By estimating the polymer weight to medium volume ratio, 
it can be determined that even if the silver contained in the polymer completely 
released on the first day, the silver ion concentration would be far below 0.05 ppm, 
and thus it would have a negligible effect to planktonic cells. 
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Fig. 3-6. The bar graph shows how silver concentrations affect a cell population after 
2 hours silver ion treatment. No major effect was observed for a silver ion 
concentration up to 0.05 ppm. 
 
 
Fig. 3-7. After 100 times dilution of the initial cell population, 0.05 ppm of silver ion 
starts to show some killing effects. 
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3.4 Standard curve and silver determination  
CdS QDs solution (5 × 10−4mol ∙ L−1) was successfully synthesized. The solution is 
transparent and has a light yellow-green color. The absorbance spectrum of the 
product was collected using a UV-spectrophotometer. Fig. 3-8 shows the absorbance 
spectrum of CdS QDs at a concentration of 5 × 10−4mol ∙ L−1  (DI water as 
background). An absorbance peak at 378 nm was observed, which indicates that UV 
light with wavelength around 380 nm is a proper excitation light source. 
 
 
Fig. 3-8. Absorbance spectrum of cadmium sulfide quantum dots sample 
 
The fluorescence spectra of CdS QDs with different silver concentration were 
collected with a fluorescence spectrophotometer. The Fig. 3-9 shows that increasing 
the silver concentration in the system can significantly boost the fluorescence 
intensity. Additionally, each of these spectra has a peak around 600 nm wavelength, 
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and only a slightly shift of the position of peak was observed at low silver 
concentration (6 × 10−5g ∙ L−1). Fig. 3-11 and Fig. 3-12 show the scatter plot of 
fluorescence intensity of the system in respect to silver ion concentration and a 
standard curve calculated by linearizing the data in the form of C/I in respect to C. 
These results indicate that the synthesized CdS QDs were able to differentiate the 
difference of silver concentration in the system.  
 
Fig. 3-9. Fluorescence spectra of CdS QDs with different concentration of silver. 
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Fig. 3-10. The scatter plot shows the overall fluorescence intensity increases 
following the increase of silver ion concentration. 
 
Fig. 3-11. The plot shows the standard curve calculated by linearized the scatter plot 
of fluorescence intensity in respect to silver ion concentration. 
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Fig. 3-12 shows the release of silver of PCL-POSS with 1% silver nitrate. The silver 
concentration on the 2nd day was failed to collected due to the little amount of silver in 
the system. Silver concentration on the 4th day is detectable but the concentration of 
silver was very low. Only about 0.5% of total silver was released. After another 4 
days, the amount of silver released increased from 0.49% of total silver to 0.82% of 
total silver. This result indicates that the release of silver of PCL-POSS is insufficient, 
and the reason needs further study.  
 
 
Fig. 3-12. Silver release of a PCL-POSS sample in DI water over time 
 
Fig. 3-13 shows the release of silver of POSS-PEG with 1% silver nitrate. The figure 
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for any further. From the 2nd day to the 14th day, the silver concentration increased 
steadily at a much lower rate, averagely 0.2% of total silver was released on each day.  
 
Fig. 3-13. Silver release of a POSS-PEG sample in DI water over time 
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4 DISCUSSION 
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According to the result, the overall amount of biofilm formed on PCL-POSS control 
and silver&BF-8 contained group is lower than the previous test on POSS-PEG 
samples without silver. The two sets of tests were carried out under identical 
conditions except for the materials tested. Therefore, the difference in the amount of 
biofilm formed could possibly be the result of different surface properties. One thing 
worth mentioning is that during the test, the surface of PCL-POSS samples, including 
silver&BF-8 containing and control groups, have prominent hydrophobicity. 
According to the protocol, samples should be fully soaked with water and have air 
bubbles removed before the tests. However, due to the high hydrophobicity, even with 
the help of sonication bath, the soaking process is difficult. Normally, hydrophilic 
surfaces are easier for cell attachment; thus, biofilms form faster on hydrophilic 
surfaces than on hydrophobic surfaces. The difference in hydrophilicity between 
PCL-POSS and POSS-PEG could cause the observed difference in biofilm resistance. 
In this case, although the high hydrophobicity reduces biofilm formation, it also 
indicates that the PCL-POSS is a material with low gas/water exchange efficiency 
which makes it an undesired material for wound dressing. 
 
The release of silver ions was measured using CdS QDs as fluorescent probes. The 
results in Fig. 3-12 show that the silver release of PCL-POSS samples was much 
slower than expected. Therefore, all samples were diluted 10 times less than what 
described in the original protocol. Even though, samples collected during the first 4 
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days contained too little silver to detect with this method. Samples collected from the 
4th day reached the lower limit of detection range. The results indicate that only about 
0.5% of total silver nitrate was released to DI water after 4 days. This rather slow 
silver ion release explains why silver in PCl-POSS shows no inhibition effect on 
biofilm growth. To effectively kill/ inhibit biofilm growth, a required concentration of 
silver ion must be reached. Alternatively, this result may indicate that the majority of 
silver ions released in early days are near the surface, which needs to be further tested. 
If the latter case is true, cells cannot easily form biofilm to the surface (due to high 
silver ion concentration), while silver ions released to the solution have negligible 
effects on planktonic cells (due to low silver ion concentration). Since the release of 
silver ions is very slow, even the surfaces of samples were not capable of sustaining a 
silver ion concentration high enough to inhibit biofilm growth. This limited silver 
release could be caused by the high hydrophobicity of the surface of PCL-POSS 
which could impede ion exchange from samples to the aqueous phase. Future study is 
needed to adjust the hydrophobicity for better silver release and longer inhibition of 
biofilm formation. The test with POSS-PEG was quite a different story. A significant 
burst silver release was observed at an early stage of the test (the first day) following a 
slow and steadily silver release during the rest of the test. Over 93% of total silver 
were not released from the sample at the end of the test. Considering the POSS-PEG 
with 1% silver nitrate showed good long-term biofilm inhibition during 14 days, if the 
synthesis/ manufacture of POSS-PEG can be improved in further research to reach 
higher silver release rate, POSS-PEG may have better inhibition effects on biofilm.  
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5 CONCLUSION 
In this study, POSS-PEG with 1% silver nitrate, POSS-PEG with 1% silver 
sulfadiazine, and PCL-POSS with 1% silver and 1% BF-8 were tested by performing 
long-term biofilm tests. Microscopic images were collected to observe the biofilm 
formation, and then exported to COMSTAT to calculate biomass. Additionally, drop 
plate method was performed to study the effect of silver released from POSS-PEG on 
planktonic cells. POSS-PEG with 1% silver nitrate and POSS-PEG with 1% silver 
sulfadiazine show similar inhibition effect on biofilm formation. Over 70% biofilm 
reductions were observed at the end of the 14-day test. PCL-POSS, a new polymer 
mat contain 1% silver nitrate and 1% BF-8, has undesirable high hydrophobicity on 
surface. The hydrophobicity could be the cause of low rate of silver release which fail 
to inhibit biofilm formation. A novel chemical analysis method recently reported, 
“using CdS QDs as fluorescence probe to measure silver concentration”, was studied 
and performed to measure the release of silver of several polymers. Experiments were 
done to prove the feasibility of this method. The silver release profiles suggest the 
majority of silver was not released. For POSS-PEG, the result shows there was a burst 
release of silver at the very early stage of silver release test following a slow and 
steadily release. Further study is needed to confirm these results. 
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6 APPENDIX 
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1L LB medium recipe 
Add following to 800mL DI water: 
NaCl 10g 
Tryptone 10g 
Yeast extract 5g 
Adjust volume to 1L with DI water, then sterilize by autoclaving. 
 
1L Phosphate-buffered saline (PBS) 
Add following to 800mL DI water: 
NaCl 8g 
KCl 0.2g 
Na2HPO4 1.44g 
KH2PO4 0.24g 
Adjust pH value to 7.4 with HCl, and then adjust volume to 1L with DI water. 
Sterilized solution by autoclaving. 
 
Quantum dots solution for silver ion determination 
PBS 500 μL 
L-cysteine (1.0 × 10−2mol/L) 100 μL 
Silver contained sample 100 μL 
QD (5.0 × 10−4𝑚𝑜𝑙/𝐿) 150 μL 
Adjust total volume to 10 mL with DI water. 
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